Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

da admin | Nov 11, 2020 | COVID-19

Non hai il permesso di visualizzare questo contenuto.

GI symptoms as early signs of COVID-19 in hospitalised Italian patients

da admin | Nov 11, 2020 | COVID-19

GI symptoms as early signs of COVID-19 in hospitalised Italian patients Buscarini E, Manfredi G, Brambilla G, et AL Gut Visualizza...

Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis – a prospective randomized study

da admin | Set 15, 2020 | BUTIRRATO

Accesso consentito agli utenti abilitati. Clicca qui per accedere

Review article: the role of butyrate on colonic function

da admin | Set 10, 2020 | BUTIRRATO

Accesso consentito agli utenti abilitati. Clicca qui per accedere
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

da admin | Set 10, 2020 | IBD

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease Sonia Facchin,  Nicola Vitulo, Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D’Incà,...
Post successivi »

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it